[1]
Acikgoz, Y., Ergun, Y., Ucar, G., Dirikoc, M. and Uncu, D. 2019. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-positive metastatic breast cancer patients. Acta Medica. 50, 4 (Dec. 2019), 14–19. DOI:https://doi.org/10.32552/2019.ActaMedica.395.